JW Pharmaceutical Corporation (KRX:001065)

South Korea · Delayed Price · Currency is KRW · Preferred Stock

20,650

-100 (-0.48%)

Jul 21, 2026, 3:30 PM KST

-30.94% (1Y)

Market Cap	729.69B +34.6%
Revenue (ttm)	775.30B +7.8%
Net Income	61.51B -5.4%
EPS	2,534.00 -4.2%
Shares Out	n/a
PE Ratio	11.86
Forward PE	n/a
Dividend	675.00 (3.25%)
Ex-Dividend Date	Mar 31, 2026

Volume	78
Open	20,050
Previous Close	20,750
Day's Range	20,050 - 20,650
52-Week Range	19,710 - 30,300
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base... [Read more]

Industry Pharmaceutical Preparations

Sector Healthcare

Founded 1945

Employees 1,068

Stock Exchange Korea Stock Exchange

Ticker Symbol 001065